Literature DB >> 4117203

Ancrod, heparin, and -aminocaproic acid in simian Knowlesi malaria.

H A Reid, P Sucharit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117203     DOI: 10.1016/s0140-6736(72)92716-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Prolonged defibrination syndrome after bite by the carpet viper Echis carinatus.

Authors:  H A Reid
Journal:  Br Med J       Date:  1977-11-19

Review 2.  The treatment of malaria.

Authors:  A P Hall
Journal:  Br Med J       Date:  1976-02-07

3.  Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes.

Authors:  L Xiao; C Yang; P S Patterson; V Udhayakumar; A A Lal
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 4.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

Review 5.  Other pathological processes in malaria.

Authors:  B Maegraith
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

6.  Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy.

Authors:  John W Avery; Geoffrey M Smith; Simon O Owino; Demba Sarr; Tamas Nagy; Stephen Mwalimu; James Matthias; Lauren F Kelly; Jayakumar S Poovassery; Joab D Middii; Carlos Abramowsky; Julie M Moore
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

7.  Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria.

Authors:  Kyle D Wilson; Lorenzo F Ochoa; Olivia D Solomon; Rahul Pal; Sandra M Cardona; Victor H Carpio; Philip H Keiser; Astrid E Cardona; Gracie Vargas; Robin Stephens
Journal:  J Neuroinflammation       Date:  2018-06-04       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.